BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG BIOCEUTICAL INNOVATIONS
Updated on September 1, 2021 — Creative Commons Attribution 4.0
Published on May 14, 2020 and updated on September 1, 2021
Erdal Can Alkoclar
Erdal Can Alkoclar is a Turkish Inventor, Scientist and Investor. Alkoclar is the co-founder and running president of Mas Pharmaceuticals . He is the sole inventor of 143 applied and 282 pending patents; 44 of them being in current PCT protection. Alkoclar is the rightsholder and Applicant of the…
- Creative Commons Attribution 4.0
- Creation date
- May 14, 2020
- Latest resource update
- May 17, 2020
WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.
WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.
ERDAL CAN ALKOCLAR & METEHAN YESIL
Community resources 0
You have built a more comprehensive database than those presented here? This is the time to share it!
Explore the reuses of this dataset.
Did you use this data ? Reference your work and increase your visibility.
Discussion between the owner and the community about this dataset.